Sign Up Now to Download a Free Research Report on

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Synergy Pharmaceuticals, Inc.

Synergy Pharmaceuticals shares surged 18 percent on over 8 times the average daily volume Wednesday. The company has reported that plecanatide, their treatment for chronic idiopathic constipation, met the primary and key secondary endpoints of a Phase IIb/III clinical study.

Going forward ... (see research report)



RESEARCH REPORT ON Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on